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Insulinoma Presenting as an
Unusual Cause of Marital Discord
Alfred F. Shwayhat, DO, MPH, CDR, MC, USN, David Brett-Major, MD, MPH, LCDR, MC, USN,
and John A. Poremba, MD, Lt Col, USAF, MC

Months before this patient’s near collapse, the metabolic derangements
caused by his cancer manifested in his marriage. This case demonstrates
the need to consider insulinoma in healthy appearing patients who experience
behavioral disturbances that otherwise might be treated only with counseling.

I

nsulinomas are the most common of a rare entity—pancreatic
neuroendocrine tumors. The
incidence of all neuroendocrine
tumors has been described as 1 to 2
per 100,000 people.1 More than half
of all neuroendocrine tumors occur
in the gastrointestinal tract, with the
pancreas ranking after the appendix
and small bowel in site frequency.1
Specifically, insulinomas account for
four cases per million person-years,2
and they typically present with symptoms of hypoglycemia.
Here, we present the case of an insulinoma manifesting as behavioral
change that ultimately led to marital
problems and an acute episode of disorientation in a young, healthy man
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who was subsequently found to also
have a seminoma. Although we believe the two tumors to be incidental
to each other, we briefly discuss our
search of the medical literature for the
possibility of a connection.

INITIAL EXAM
A 35-year-old, white, active duty
service member was referred by his
unit’s physician for an endocrinology
evaluation after he experienced an
episode of acute disorientation. The
incident occurred one day after a vigorous run. He only had eaten a light
breakfast before the run and, due to
his work schedule, had not eaten supper the evening before. When the patient’s wife found him, he was poorly
responsive and drooling. Emergency
Medical Services was contacted, and
they observed a capillary glucose
level of 22 mg/dL. Intravenous dextrose was administered with rapid
improvement in symptoms.
Upon endocrinology evaluation,
the patient—who was in otherwise
good health—reported experiencing
moodiness and poor concentration
for the past year. In fact, two months
before the incident, the patient said
he and his wife (a nurse) had entered
counseling for marital problems.
His wife had become frustrated with

his increasing distractedness and
unreliability for chores and declining contributions in the care of their
young child. During this same time
period, the patient reported experiencing sporadic episodes of fatigue,
particularly after exercise. He reported smoking one cigar per week,
drinking approximately one alcoholic
beverage per day, and no exposure to
illicit substances. He described himself as physically active and jogged
and lifted weights for exercise three
to five times per week.
The patient’s medical history included seasonal rhinitis and sinusitis. He had no surgical history and
took no prescription medications, although he reported sporadically using
over-the-counter fexofenadine, pseudoephedrine, guaifenisin, ibuprofen,
and acetaminophen. The patient
stated that his mother and maternal
grandmother had problems with low
blood sugar. He was unsure of any
further history, however, and denied
that they had ever experienced complications or were found to have any
tumors. His family history was otherwise unremarkable.
Results of physical examination
and baseline laboratory studies (including complete blood count with
differential, complete metabolic panel,
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cholesterol panel, and iron studies)
were normal. An adrenocorticotropin
stimulation test was conducted. His
baseline, 30-minute, and 60-minute
serum cortisol levels were 25.4, 32.3,
and 41.5 µg/dL, respectively (morning baseline reference range, 5 to 25
µg/dL). The patient was admitted for
a 72-hour fast test, conducted in accordance with the Mayo Protocol.3
During the fast, the patient was
allowed only water and underwent
blood collection every four hours. He
was mildly anxious throughout the
test, but was able to continue with
frequent reassurance. His serum glucose levels were between 30 and 45
mg/dL during the initial 40 hours of
the study. Forty-one hours into the
fast, the patient became somnolent.
He was disoriented and answered
questions with tangential sentence
fragments. Additional blood collections were obtained and intravenous
glucagon was administered. The
patient quickly recovered. He was
maintained on a dextrose in water intravenous drip for six hours and fed.
When the patient was found somnolent, his serum glucose value was
22 mg/dL—which increased to 44
mg/dL after the administration of
glucagon. His serum insulin value
during hypoglycemia was elevated
at 28.7 µIU/mL. His serum proinsulin and C-peptide levels also were
elevated at 21.3 pmol/L (reference
range, 0 to 17.4 pmol/L) and 3.4 ng/
mL (reference range, 0.8 to 3.1 ng/
mL), respectively. Results of a urine
sulfonylurea screen were negative.
The patient’s serum beta-OH-butyrate
level was slightly elevated, however,
at 0.8 mmol/L (reference range, 0 to
0.3 mmol/L).
The patient was diagnosed with
endogenous hyperinsulinemia. Computed tomography (CT) scan of the
abdomen revealed a 1.1-cm exophytic
mass on the body of the pancreas
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without evidence of metastasis (Figure 1). Results of an octreotide scan
were negative.

TREATMENT COURSE
Laparoscopic excision of the mass
was performed. Subsequent pathology confirmed a neuroendocrine
tumor consistent with insulinoma
(Figure 2).
The patient did well postoperatively. He experienced normalization
of his serum fasting glucose levels.
His serum calcium, prolactin, and gastrin levels were normal and multiple
endocrine neoplasia type 1 (MEN1)

was excluded as a syndromic cause of
insulinoma. He and his wife reported
increased marital accord.
Two months after the diagnosis of
his insulinoma, the patient identified
a left testicular mass on self-examination—although a normal genital examination had been completed upon
his prior endocrinology admission.
He was referred to the urology department, and a local, 1.5-cm seminoma
was removed. The patient continues
to do well after resection of this lesion, with semi-annual follow-up in
both the endocrinology and urology
departments.

CASE IN POINT

Table 1. Clinical classification of drug-caused hypoglycemic
disorders according to appearance of patient2
Healthy appearing patient with no coexisting disease
v Ethanol
v Salicylates
v Quinine
v Haloperidol
Healthy appearing patient with coexisting disease
v Any drug containing sulfhydryl or thiol and autoimmune insulin
syndrome
v Dispensing error
v Disopyramide
v Beta-adrenergic–blocking agents
Figure 1. Computed tomography scan of
the patient’s abdomen showing a hyperdense, 1.1-cm exophytic mass along the
pancreatic body.

Figure 2. Histopathologic slide of the patient’s neuroendocrine tumor (400 X magnification).

ABOUT THE CONDITION
The clinical presentation of hypoglycemia can range from symptoms of
headache, nervousness, and anxiety
in mild cases to seizure, coma, and
death in the most severe cases. Presentation depends in part on etiology,
the clinical state of the patient, and
whether physiologic compensatory
mechanisms are ineffective.

Ill appearing patient
v Pentamadine for pneumocystis pneumonia
v Trimenthoprim-sulfamethoxazole and renal failure
v Propoxyphene and renal failure
v Quinine for cerebral malaria
v Quinidine for malaria
v Topical salicylates and renal failure

The differential diagnosis of hypoglycemia is broad. A clinically useful
tool to guide the workup of cause for
hypoglycemia—whether it be drug
induced (Table 1) or brought on by
a predisposing condition (Table 2)—
based on the severity of the patient’s
presentation was proposed in 1995.2
In addition to this guide, the author
provided a diagnostic algorithm for
hypoglycemia.
In the case reported here, the patient’s age at onset, occupation, and
social situation led to an initial differential that included factitious hypoglycemia; intense exercise coupled
with poor nutrition; alcohol use; adrenal insufficiency; occult infection,
such as malaria; and insulinoma. We
diagnosed endogenous hyperinsulinemia as the etiology for the patient’s
hypoglycemia given the presence of
elevated serum insulin and C-peptide
levels and the absence of sulfonylurea
in the patient’s urine.

Insulinomas occur in isolation or,
about 7% to 8% of the time, as part of
a syndrome.3 Less commonly they
occur as tuberous sclerosis or von
Hippel-Lindau syndrome.
Our patient presented with neuroglycopenia. This metabolic abnormality may manifest as personality or
behavioral change, confusion, cognitive decline, vision changes, amnesia, seizures, or coma.3,4 The patient’s
history of distractedness and family
tension, as well as the anxiety he displayed, may represent his compensatory counter-regulatory hormone
surge and history of subclinical and
transient hypoglycemic episodes.
Fortunately, our patient had a sporadic, solitary lesion amenable to resection by video laparoscopy.
The optimal approach to treatment, even in the setting of multiple
metastatic lesions, is considered to
be localization by CT scan followed
by surgical resection. If the tumor is
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Table 2. Clinical classification of predisposing
condition–caused hypoglycemic disorders
according to appearance of patient2
Healthy appearing patient with no coexisting disease
v Insulinoma
v Factitious hypoglycemia induced by insulin
v Intense exercise
v Ketotic hypoglycemia
Healthy appearing patient with coexisting disease
v Ackee-fruit poisoning and undernutrition
Ill appearing patient
v Small size for gestational age in infants
v Backwith-Wiedemann syndrome
v Erythroblastosis fetalis
v Hyperinsulinemia in infants due to maternal diabetes
v Glycogan storage disease
v Defects in amino acid and fatty acid metabolism
v Reye syndrome
v Cyanotic congenital heart disease
v Hypopituitarism
v Isolated growth hormone deficiency
v Isolated corticotropin deficiency
v Addison disease
v Galactosemia
v Hereditary fructose intolerance
v Carnitine deficiency
v Defective type 1 glucose transporter in the brain
v Acquired severe liver disease
v Large non–beta-cell tumor
v Sepsis
v Renal failure
v Congestive heart failure
v Lactic acidosis
v Starvation
v Anorexia nervosa
v Surgical removal of phaochromocytoma
v Insulin-antibody hypoglycemia
Hospitalized patient
v Hospitalization for a predisposing illness
v Total parenteral nutrition and insulin therapy
v Interference of cholestyramine with glucocorticoid absorption
v Shock

not localized by preoperative imaging, intraoperative ultrasound can be
utilized along with calcium infusion
and stimulation if indicated.

An insulinoma-seminoma
connection?
A Medline search revealed no literature with a clear link of insulinoma

with seminoma, and we believe that
ours is the first documented case of
these tumors coexisting in a patient.
One study described the occurrence
of these tumors in five-week-old rats
exposed to radiation but none of the
rats were reported to develop both insulinoma and seminoma.5 Our patient
had no known history of prior irradiation; therefore, the coexistence of
these tumors was likely coincidental.
While our patient showed no signs
of tuberous sclerosis or von HippelLindau syndrome, there may be links
between these disorders and testicular tumors. Leydig cell tumors and
testicular interstitial neuroendocrine
tumors are sometimes grouped with
pancreatic tumors in animal studies
and may be related, but there is no
known link between seminoma and
insulinoma. We found a single case
report that cites Leydig cell tumor
in a patient with tuberous sclerosis.6
While it has been postulated that the
trophic effect of insulin or insulin-like
growth factor may have a role in the
development of germ cell tumors, one
observational study demonstrated an
inverse relationship between the concentration of insulin-like growth factor and the risk of germ cell tumor.7
Overall, insufficient evidence exists to
associate insulinomas with seminomatous testicular cancer.

IN CONCLUSION
While rare, insulinomas are discoverable and treatable. Since clinical hypoglycemia declares itself with a wide
range of neurobehavioral signs and
symptoms, changes in behavior in a
given patient can lead to the identification of metabolic derangement.
This case, in particular, demonstrates
the need to consider metabolic derangements in patients who experience behavioral disturbances that
are initially treated with counseling.
When evaluating for hypoglycemia,
Continued on page 21
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a 72-hour fast is a useful diagnostic
●
intervention when indicated.
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